中药药理与毒理学领域的科研绩效评价——基于InCitesTM平台的文献计量分析

Performance evaluation of scientific research in pharmacology and toxicology of Chinese medicine——Bibliometric analysis based on InCites platform

目的对2000~2017年间的中药药理与毒理学文献进行文献计量学分析,为相关领域的研究提供借鉴。方法利用In CitesTM平台,选择2000-2017年Web of Science(以下简称Wo S)数据库收录的中药药理与毒理学文献为研究对象,从发文量、国际合作情况、期刊、基金资助四个方面等进行统计分析。结果 2000~2017年间,Wo S中收录有关中药药理与毒理学方面的论文一共有5058篇,被引73068次,其中高被引论文33篇,其中国际合作论文共710篇。中国发表Wo S论文共3582篇,发文量居世界第一,其中以中美合作居多。中药药理与毒理学近二十年间的Wo S论文刊登在245种期刊上,一共有来自全球203个基金资助机构进行研究资助。结论要建立以创新和质量为导向的科研评价体系,加大学科发展力度,提升学术影响力,并且要加强国际科研与合作,建设高质量研究团队。

Objective To provide reference for the research in the related fields by analyzing the literature of pharmacology and toxicology of Chinese medicine in the past 2000 -2017 years. Methods Based on the InCites platform, we selected the literature of pharmacology and toxicology of Chinese medicine collected from WoS database in 2000 -2017 years as the research object. According to bibliometric analysis method, we statistically analyzed those papers from the aspects of the number of papers, international cooperation, periodicals as well as fund support. Results During the 2000 -2017 years, there were 5058 papers on pharmacology and toxicology of Chinese medicine in WoS, which were cited 73068 times, including 33 highly cited papers and 710 international cooperation papers. The number of papers published by Chinese is 3582 ,which is the first in the world, and the majority of those papers with international cooperation are between China and the United States. In recent twenty years, WoS papers in pharmacology and toxicology of Chinese medicine have been published in 245 journals. A total of 203 funding agencies from all over the world have supported the research. Conclusion We should establish an innovative and quality oriented research evaluation system, promote discipline development and enhance academic influence, as well as strengthen international research and cooperation and build high -quality research teams.